DIAGNOSTICS

Diagnostics
The Issue

Accurate diagnosis requires the right mix of affordable and high-quality technology and health system efficiency. Not only is it important to choose the right technologies for each healthcare setting, there are also several essential health services that need to be functioning around the laboratory for testing to be delivered effectively.

Many countries are still working to establish both the technology infrastructure and the associated health systems required. As such, testing remains a critical gap for many diseases.

The COVID-19 pandemic brought this into sharp focus. Providing testing rapidly became an enormous priority for countries, not only for individual patient care, but also to track and manage spread of the disease for pandemic control.

CHAI's Approach

CHAI’s Global Diagnostics Team works closely with country partners and other agencies to improve access to high-quality, affordable diagnostics for COVID-19, HIV, cervical cancer, tuberculosis (TB), malaria, hepatitis, diabetes, and overall diagnostics delivery services in low- and middle-income countries. CHAI takes a patient-centric and holistic approach that focuses on introducing innovative diagnostic technologies and delivery systems that are proven through evidence generation, catalytic adoption, and scale-up by national governments.

CHAI helps establish the conditions to support high-quality diagnostic systems, especially for primary health care. We work closely with government partners to secure buy-in and support, updating policies and strategies, establishing supply chain and training systems, and activating and expanding testing capacity. We also help build diagnostic networks that maximize testing coverage and referral to care and reduce costs. Our focus is on accelerating access to high-quality and affordable diagnostics through coordinated engagement with both the supply and demand sides of the market.

Results
120M
affordable high-quality COVID-19 rapid antigen tests made available for LMICs
20+
countries helped with introducing and scaling-up rapid point-of-care PCR-based tests for HIV, TB, hepatitis, and COVID-19
US$1
lower pricing negotiated for dual HIV and syphilis rapid tests
<$10
negotiated price for HIV viral load in low and middle-income countries, saving more than $150M
Our Work

November 15, 2021

MedAccess, CHAI, SD Biosensor to make syphilis, HIV dual rapid test available for under US$1 in low- and middle-income countries

The point-of-care rapid diagnostic test enables simultaneous diagnosis of both syphilis and HIV in under 20 minutes from a single finger-prick sample.

Read More

September 28, 2020

Global partnership to make available 120M affordable, quality COVID-19 rapid tests for low- and middle-income countries

  A full access package includes WHO policy guidance on the use of antigen-based rapid diagnostic tests, manufacturer volume guarantees for low- and middle-income countries, catalytic funding to assist governments to deploy the tests, and an initial US$50M procurement fund Several rapid, point-of-care antigen tests are being assessed by WHO for Emergency Use Listing (EUL)...

Read More
Three health workers in Vietnam huddle over a small table looking through paperwork.

April 28, 2020

Unitaid and CHAI announce agreement with Omega Diagnostics to increase access to device-free CD4 testing technology

Agreement with Omega Diagnostics will help deliver same-day CD4 testing for people living with HIV in over 130 low- and middle-income countries at just US$3.98 per test.

Read More

July 25, 2018

Breakthrough agreement will reduce costs and increase access to diagnostic technology for millions in low- and middle-income countries

Amsterdam – A breakthrough pricing agreement will significantly reduce the cost of diagnostic testing for HIV/AIDS, hepatitis and cervical cancer for millions of people in low- and middle-income countries. Diagnostic testing improves patient care, helps prevent the spread of disease, and reduces healthcare spending. The new agreement, announced today at the 2018 International AIDS Conference,...

Read More

July 25, 2018

Breakthrough agreement will reduce costs and increase access to diagnostic technology for millions in low- and middle-income countries

Amsterdam – A breakthrough pricing agreement will significantly reduce the cost of diagnostic testing for HIV/AIDS, hepatitis and cervical cancer for millions of people in low- and middle-income countries. Diagnostic testing improves patient care, helps prevent the spread of disease, and reduces healthcare spending. The new agreement, announced today at the 2018 International AIDS Conference,...

Read More
Three health workers in Vietnam huddle over a small table looking through paperwork.

April 28, 2020

Unitaid and CHAI announce agreement with Omega Diagnostics to increase access to device-free CD4 testing technology

Agreement with Omega Diagnostics will help deliver same-day CD4 testing for people living with HIV in over 130 low- and middle-income countries at just US$3.98 per test.

Read More

November 15, 2021

MedAccess, CHAI, SD Biosensor to make syphilis, HIV dual rapid test available for under US$1 in low- and middle-income countries

The point-of-care rapid diagnostic test enables simultaneous diagnosis of both syphilis and HIV in under 20 minutes from a single finger-prick sample.

Read More

September 28, 2020

Global partnership to make available 120M affordable, quality COVID-19 rapid tests for low- and middle-income countries

  A full access package includes WHO policy guidance on the use of antigen-based rapid diagnostic tests, manufacturer volume guarantees for low- and middle-income countries, catalytic funding to assist governments to deploy the tests, and an initial US$50M procurement fund Several rapid, point-of-care antigen tests are being assessed by WHO for Emergency Use Listing (EUL)...

Read More

Join the Team

CHAI is looking for dynamic and self-motivated individuals who are committed to strengthening health systems around the world and expanding access to care and treatment of HIV/AIDS, malaria, and other illnesses.

View All CHAI Positions View Program Positions

Join the Team

CHAI is looking for dynamic and self-motivated individuals who are committed to strengthening health systems around the world and expanding access to care and treatment of HIV/AIDS, malaria, and other illnesses.

View All CHAI Positions View Program Positions